Matches in Wikidata for { <http://www.wikidata.org/entity/Q93091210> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- Q93091210 description "artículu científicu espublizáu en setiembre de 2019" @default.
- Q93091210 description "scientific article published on 04 September 2019" @default.
- Q93091210 description "wetenschappelijk artikel" @default.
- Q93091210 description "наукова стаття, опублікована 4 вересня 2019" @default.
- Q93091210 name "Population Pharmacokinetics of Galcanezumab, an Anti-CGRP Antibody, Following Subcutaneous Dosing to Healthy Individuals and Patients With Migraine" @default.
- Q93091210 name "Population Pharmacokinetics of Galcanezumab, an Anti-CGRP Antibody, Following Subcutaneous Dosing to Healthy Individuals and Patients With Migraine" @default.
- Q93091210 type Item @default.
- Q93091210 label "Population Pharmacokinetics of Galcanezumab, an Anti-CGRP Antibody, Following Subcutaneous Dosing to Healthy Individuals and Patients With Migraine" @default.
- Q93091210 label "Population Pharmacokinetics of Galcanezumab, an Anti-CGRP Antibody, Following Subcutaneous Dosing to Healthy Individuals and Patients With Migraine" @default.
- Q93091210 prefLabel "Population Pharmacokinetics of Galcanezumab, an Anti-CGRP Antibody, Following Subcutaneous Dosing to Healthy Individuals and Patients With Migraine" @default.
- Q93091210 prefLabel "Population Pharmacokinetics of Galcanezumab, an Anti-CGRP Antibody, Following Subcutaneous Dosing to Healthy Individuals and Patients With Migraine" @default.
- Q93091210 P1433 Q93091210-3A9C8860-82E5-4CD3-8B2C-BDE15508EA34 @default.
- Q93091210 P1476 Q93091210-72072EC8-7C12-45F6-9C77-D4B3DE55ABEA @default.
- Q93091210 P2093 Q93091210-0D35277B-04B3-4194-B925-9F88E60C8075 @default.
- Q93091210 P2093 Q93091210-3FC3E742-FF0A-425B-8096-0AB9D216B6C6 @default.
- Q93091210 P2860 Q93091210-166A320C-6239-4189-9E01-79A504A13309 @default.
- Q93091210 P2860 Q93091210-1C9981E9-C147-444B-AAF7-61FD753F209D @default.
- Q93091210 P2860 Q93091210-3EE9FD8A-AADB-498B-ACB1-720850301244 @default.
- Q93091210 P2860 Q93091210-5491A053-8344-4F12-99F6-B85A405866D7 @default.
- Q93091210 P2860 Q93091210-56A732C4-D179-4741-BDC9-EAC6E092CB0A @default.
- Q93091210 P2860 Q93091210-75C13462-7332-4034-AF12-1917DE37057F @default.
- Q93091210 P2860 Q93091210-7C5710FC-527B-4AE5-BE6D-6DB1CCA81868 @default.
- Q93091210 P2860 Q93091210-8239D58C-A6DD-43CC-A1D3-423611548D87 @default.
- Q93091210 P2860 Q93091210-9885ABFB-CF11-4CC0-8F63-542271D8DFEF @default.
- Q93091210 P2860 Q93091210-A053274A-B85E-4375-A63A-9A60E13A61CD @default.
- Q93091210 P2860 Q93091210-A9105160-2ED7-4074-90A0-38355ADD8DDC @default.
- Q93091210 P2860 Q93091210-AEC303B3-4793-4869-9662-5AF8F22DF4CB @default.
- Q93091210 P2860 Q93091210-B12D5B17-97D6-4653-8A3B-2FE8BAD1A53E @default.
- Q93091210 P2860 Q93091210-B34B8649-1B18-465C-9D45-EF65B3F64B3E @default.
- Q93091210 P2860 Q93091210-C8BF76BF-7729-486E-A3E2-F1A11CC98178 @default.
- Q93091210 P2860 Q93091210-EAA87C7D-EC7F-4329-B999-921648B2E555 @default.
- Q93091210 P2860 Q93091210-FA4B010B-4C0F-49D2-8606-01677985BD2C @default.
- Q93091210 P304 Q93091210-6810D74D-374F-4089-ACA1-3AD180322646 @default.
- Q93091210 P31 Q93091210-0B725826-3B3D-4239-ACF5-5F95AFD5AE10 @default.
- Q93091210 P356 Q93091210-D8D44D95-B145-40DE-9E27-E332F7FAED5B @default.
- Q93091210 P433 Q93091210-E1D122DC-327D-4979-9AD2-7D8DF5F35E4A @default.
- Q93091210 P478 Q93091210-B1F63AC6-C09B-4E2F-98AD-5C0F2793D3BE @default.
- Q93091210 P577 Q93091210-A59354FD-CCC9-4A16-BD95-6DAF16474BAC @default.
- Q93091210 P698 Q93091210-933AEEBA-0563-4364-BC6A-8B30777DC2A6 @default.
- Q93091210 P921 Q93091210-2F5958BB-E83C-4309-ACCD-E0D1B7981CE2 @default.
- Q93091210 P932 Q93091210-B41D0A09-1181-40D2-A929-516E342E8064 @default.
- Q93091210 P356 JCPH.1511 @default.
- Q93091210 P698 31482569 @default.
- Q93091210 P1433 Q7743562 @default.
- Q93091210 P1476 "Population Pharmacokinetics of Galcanezumab, an Anti-CGRP Antibody, Following Subcutaneous Dosing to Healthy Individuals and Patients With Migraine" @default.
- Q93091210 P2093 "Tonya Quinlan" @default.
- Q93091210 P2093 "William Kielbasa" @default.
- Q93091210 P2860 Q30499990 @default.
- Q93091210 P2860 Q34110768 @default.
- Q93091210 P2860 Q35897211 @default.
- Q93091210 P2860 Q37974649 @default.
- Q93091210 P2860 Q38876360 @default.
- Q93091210 P2860 Q43529181 @default.
- Q93091210 P2860 Q43885764 @default.
- Q93091210 P2860 Q47663546 @default.
- Q93091210 P2860 Q47677099 @default.
- Q93091210 P2860 Q50867897 @default.
- Q93091210 P2860 Q57074573 @default.
- Q93091210 P2860 Q60960553 @default.
- Q93091210 P2860 Q64948279 @default.
- Q93091210 P2860 Q81951721 @default.
- Q93091210 P2860 Q87256004 @default.
- Q93091210 P2860 Q88921805 @default.
- Q93091210 P2860 Q92655580 @default.
- Q93091210 P304 "229-239" @default.
- Q93091210 P31 Q13442814 @default.
- Q93091210 P356 "10.1002/JCPH.1511" @default.
- Q93091210 P433 "2" @default.
- Q93091210 P478 "60" @default.
- Q93091210 P577 "2019-09-04T00:00:00Z" @default.
- Q93091210 P698 "31482569" @default.
- Q93091210 P921 Q323936 @default.
- Q93091210 P932 "6972493" @default.